Standard Maintenance

DRUG3 trials

Sponsors

Kaiser Permanente, Fondazione Italiana Linfomi - ETS, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Conditions

Follicular Non-Hodgkin's LymphomaObesityPsoriasisPsoriasis (PsO)

Phase 3

Study to Evaluate the Efficacy of Response-adapted Strategy in Follicular Lymphoma

CompletedNCT02063685

Fondazione Italiana Linfomi - ETSFollicular Non-Hodgkin's Lymphoma

Start: 2012-07-31End: 2021-12-31Updated: 2022-06-21

Unknown Phase

Adaptation of the Diabetes Prevention Program for Primary Care

CompletedNCT01220089

Kaiser PermanenteObesity

Start: 2010-10-31End: 2015-08-31Updated: 2020-01-30

Effects of Different Secukinumab Maintenance Regimens on Long-Term Outcomes in Patients With Psoriasis

Not yet recruitingNCT07642544

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPsoriasis, Psoriasis (PsO)

Start: 2026-06-01End: 2027-03-01Target: 120Updated: 2026-06-11

Related Papers

Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi

Blood Advances2025-03-191 citations

PET Radiomics Discriminate Among Different Lymphoma Sub-Types

Blood2024-11-051 citations

The Prognostic Value of MTV Is Retained in New Proposed SUV 4 Threshold: An International Comparison of Follicular and Hodgkin Patient Survival

Blood2024-11-05

End of induction [<sup>18</sup>F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial.

2024-05-258 citations

Prognostic value of the end of induction PET in patients with follicular lymphoma: results from the analysis of FOLL 12 trial

Hematological Oncology2023-06-01

The impact of spleen metabolic tumor volume on total metabolic tumor volume and prognosis in patients with follicular lymphoma enrolled in FOLL 12 trial

Hematological Oncology2023-06-01

Total Metabolic Tumor Volume Is Confirmed As Independent Prognostic Factor in Treatment Naïve Follicular Lymphoma Patients and Can be Combined with FLIPI2 to Improve Prognostic Accuracy. a FOLL12 Substudy By the Fondazione Italiana Linfomi

Blood2022-11-15

Novel prognostic tools that identify high‐risk follicular lymphoma

HemaSphere2019-06-011 citations

Medication costs during an 18 month clinical trial of obesity treatment among patients encountered in primary care.

2015-05-291 citations